Principal Street Partners LLC Buys Shares of 484 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Principal Street Partners LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 484 shares of the medical equipment provider’s stock, valued at approximately $253,000.

A number of other institutional investors also recently made changes to their positions in ISRG. Ameritas Advisory Services LLC raised its position in shares of Intuitive Surgical by 24.8% in the 4th quarter. Ameritas Advisory Services LLC now owns 1,628 shares of the medical equipment provider’s stock valued at $850,000 after purchasing an additional 324 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. raised its position in shares of Intuitive Surgical by 8.0% in the 4th quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 543 shares of the medical equipment provider’s stock valued at $283,000 after purchasing an additional 40 shares in the last quarter. Harbor Investment Advisory LLC raised its position in shares of Intuitive Surgical by 10.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 2,635 shares of the medical equipment provider’s stock valued at $1,375,000 after purchasing an additional 254 shares in the last quarter. Koshinski Asset Management Inc. raised its position in shares of Intuitive Surgical by 89.9% in the 4th quarter. Koshinski Asset Management Inc. now owns 8,062 shares of the medical equipment provider’s stock valued at $4,208,000 after purchasing an additional 3,816 shares in the last quarter. Finally, Pure Financial Advisors LLC raised its position in shares of Intuitive Surgical by 1.8% during the 4th quarter. Pure Financial Advisors LLC now owns 1,505 shares of the medical equipment provider’s stock valued at $786,000 after acquiring an additional 26 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 188 shares of the firm’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares of the company’s stock, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on ISRG. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Finally, UBS Group upped their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $557.16 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00. The stock has a market cap of $199.70 billion, a price-to-earnings ratio of 86.92, a PEG ratio of 5.85 and a beta of 1.70. The business has a fifty day moving average of $508.11 and a 200-day moving average of $537.36.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.